Screener
Sarepta Therapeutics, Inc. SRPT Business Segments — Manufacturing Costs
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ManufacturingCosts.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of sales (excluding amortization of in-licensed rights) | 149,385 | 152,558 | 258,153 | 290,122 |
| Compensation and other personnel expenses | 60,725 | 89,839 | 122,655 | 182,923 |
| Up-front and collaboration license fees | — | — | 50,000 | 583,787 |
| Manufacturing expenses | 1,837 | 80,685 | 21,595 | 148,150 |
| Clinical trial expenses | 23,102 | 33,511 | 41,406 | 66,658 |
| Facility- and technology-related expenses (excluding depreciation and amortization) | 23,890 | 28,580 | 46,832 | 56,237 |
| Research and development- other (excluding non-cash items) (1) | 19,847 | 31,843 | 38,518 | 60,314 |
| Selling, general and administrative- other (excluding non-cash items) (2) | 42,462 | 56,322 | 82,655 | 107,464 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s business segments — manufacturing costs?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — manufacturing costs of $1.84M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — manufacturing costs changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — manufacturing costs decreased by 97.7% year-over-year, from $80.69M to $1.84M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — manufacturing costs?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — manufacturing costs has grown at a -23.5% compound annual growth rate (CAGR), from $466.11M to $208.83M.
- What does business segments — manufacturing costs mean?
- Includes all direct and indirect costs associated with the manufacturing and production processes of the segment's products. This metric is essential for evaluating the scalability and cost-effectiveness of the segment's supply chain operations.
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude